OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2021-03-31-accounts

Contents Pacaee
Reference and Administrative Details ofthe Charity 3 —11
Trustee's Report 12 —22
Statement ofTrustee's responsibilities 23
Independent
auditor's		 report 24-27
Foreword 28
Statement of Financial Activities 29
Balance Sheet 30
Statement of Cashflow 31
Statement ofAccounting Policies 32-36
Notes to the Financial Statements 37-48

ust Board of Di rectors (B oD) holding
office from April 2020 to January		 20 22 ar e:
Chairman John Anderson
Chief Executive Ken Bremner
Executive Directors Shahid Wahid —Executive Medical Director
Julia Pattison —Executive
Director of Finance		 —to 31
March 2021
Hayley Wardle —Executive Director of Finance —from
1 April 2021
Melanic Johnson —Executive Director of Nursing,
Midwifery
and Allied Health Professionals
Peter Sutton —Executive Director of Planning and
Business Development
Kath Griffin —Executive Director of Human Resources
and Organisational
Development
Trust Secretary/Director Andrea
Hetherington
—Director of Corporate		 Affairs
and
Legal/Trust
Secretary/Freedom
to		 Speak Up
Guardian
Non-Executive Directors Stewart Hindmarsh
David Barnes
Paul McEldon

Combined
Total Total
Notes Unrestricted Restricted Endowment 2021 2020
Funds Funds Funds Funds Funds
f000 EOOO EOOO 6000 EOOO
Income from:
Donations
&Legacies		 1,565 0 1,567 907
Grants 2.4 258 0 258
Charitable
Activities		 69 69 77
Other Trading Activities
investments 9.4 79 83 gg
Total Income 1,977 0 1,983 1,090
Expenditure
on:
Raising Funds (23) (1) 0 (24) (61)
Charitable
Activities		 (726) (98) 0 (824) (1,275)
Total Ex enditure 7 (749) (99) 0 (848) 1 336)
Net Gain/(Loss)
on investments		 9.1 388 24 0 412 (224)
Net Income) ( Expenditure 1,616 (69 0 1,547 (470)
Transfer between funds 0 0 0 0 0
Net movement
in		 funds 1,616 (69) 0 1,547 (470)
Reconciliation
of		 Funds:
Total funds brought forward 5,180 236 159 5,575 6,045
Total funds carried forward 13 6,796 167 159 7&122 5,575

Combined
Total Total
Notes Unrestricted Restricted Endowment 2021 2020
Funds Funds Funds Funds Funds
EOOO 8000 f000 6000 f000
Non current assets
Investments 9.1,9.3 3,551 161 1 3713 2104
Total non-current assets 3.551 161 1 3713 2104
Current assets
Investments 9.2 0 1,158
Trade and other receivables 10 27 27 32
Cash and cash equivalents 3,367 158 3,531 3,028
Total current assets 3,394 6 158 3,558 4,218
Current liabilities
Trade and other payables 12 (149) 0 0 (149) (747)
Net current assets 3,245 6 158 3,409 3,471
Total net assets 6,796 167 159 7,122 5,575
Retained funds of the Charity
Endowment Funds 13.1 0 0 159 159 159
Restricted Income Funds 13.3 0 167 0 167 238
Unrestricted Income Funds 13.5 6,796 0 0 6,796 5,180
Total retained funds ofthe Charit 6,796 167 159 7,122 5,575

Combined
Total
Year Ended Year Ended
31 March 21 31 March 20
R'000s 6'OOOS
Net income and expenditure for the reporting period 1,547 (470)
Decrease
in current debtors		 5 90
(Decrease) / Increase
in current		 creditors (596) 338
Net (Gain) / Loss on investments (412) 224
Net cash inflow from operating activities 542 182
Disposals at Sales Proceeds values 677 635
Acquisitions
at cost		 (716) (598)
Net Cash flow from investment activities (39) 37
Net cash inflow cash and cash equivalents 503 219
Cash and cash equivalents at beginning of the period 3,028 2,809
Cash and cash equivalents at end ofthe period 3,531 3,028

Combined
2 Unrestricted Restricted Endowment Total
2021		 Totai
2020
Funds Funds Funds Funds Funds
f000 f000 f000 f000 f000
2.1 Donations
Donations from individuals 160 162 194
Donations from charities 24 24 230
Corporate donations 1,265 1,265 327
Non corporate donations 6 6 25
1455 0 1457 776
Analysis
ofdonations		 Analysis
ofdonations		 from individuals from individuals f000 received Number ofdeposits Number ofdeposits
2021 2020 2021 2020
Individuals
giving		 &f1k 38 58 16 24
Individuals
giving		 &f100 67 94 211 348
Fundraising
-voluntary		 (not via STSFT) 21 22 50 30
Other 36 20 363 254
Totals 162 194 640 656
Combined
Total Total
Unrestricted Restricted Endowment 2021 2020
Funds Funds Funds Funds Funds
f000 f000 f000 f000 FOOO
2.2 Legacies
Rehab and Elderly Medicine 40 40 0
Medical Specialties 42 42 0
General
Internal		 Medicine 0 0 5
Ophthalmology 22 22 126
CardioThoracic
Medicine		 4 4 0
General Purposes 2 2 0
110 0 110 131
In total 10legacies were received during 2020/21 (2019/20: 4),
2.3 Total donations and legacies 1,565 0 1 567 907
Combined
Total Total
Unrestricted Restricted Endowment 2021 2020
Funds Funds Funds Funds Funds
2.4 Grants f000 f000 f000 f000 f000
Grants from Charities
NHS CT - NHS Charities Together 198 0 198
CHSA - Covid19 Healthcare Support Appeal 60 0 60
258 0 258

Combined
Income from 3 Total Total
charitable Unrestricted Restricted Endowment 2021 2020
activities Funds Funds Funds Funds Funds
f000 f000 f000 f000 f000
Course and conference fees 69 69 77
6 different course types were held (2019/20: 10).
Combined
Income from 4 Total Total
other trading Unrestricted Restricted Endowment 2021 2020
activities Funds Funds Funds Funds Funds
f000 f000 f000 f000 f000
Staff lottery
6 0 0 6 7

Analysis of 7 Investment Costs of Combined
total Costs of Management Charitable Governance Total Tote I
expenditure Fundrsising Costs Activities Costs 2821 2020
5000 f000 f000 f000 8800 5000
Other (3) 0 (647) 0 (650) (1,137)
Bought-in services from NHS (2) 0 (159) (2) (163) (171)
Investment
Broker		 fee 0 (18) 0 0 (18) (18)
Audit fees - internal audit 0 0 0 0 0 (3)
provision
Audit fees - external statutory (17) (17) (7)
audit provision
806 19 848 1,336

Traded Non C u rrent Asse t Inv es tment s:
Combined
Total Total
2021 2020
f000 f000
Managed
Porffolios
Market value at 1 April 2,104 2,370
Less: Disposals at Sales Proceeds values (677) (635)
Add: Acquisitions at cost 716 598
Net unrealised and realised gain / (loss) on sale and revaluation 427 229
Market value at 31 March 2570 2 104
Fixed Interest Fund Holding
Market value at 1 April 1,158
Less: Disposals at Sales Proceeds values 0
Add: Acquisitions at cost 0
Net unrealised and realised gain / (loss) on sale and revaluation 15
Market value at 31 March 1,143
Total non current asset investments 3,713 2104
Historic cost at 31 March-Managed Portfolios and Fixed Interest Holdin 4,139 2,268
Traded Current Asset Investments:
Combined
Total Total
2021
f000		 2020
f000
Fixed Interest Fund Holding
Market value at 1 April 1,153
Less: Disposals at Sales Proceeds values 0
Add: Acquisitions at cost 0
Net unrealised
and realised		 gain / (loss) on sale and revaluation 5
Market value at 31 March 1,158
Historic cost at 31 March Fixed Interest Holding 1,150
Combined
Total
Traded Non Current and Current Asset Investments: 31 March 31 March
2021 2020
f000 f000
Investments listed on a rec nlsed ck Exchan e
In the UK 2,091 1,940
Outside the UK 60 71
Unlisted
securities
In the UK 1,041 973
Outside the UK 521 278
Total 3,713 3,262

Combined
Analysis of 9.4 Total gross income: Total Total
gross income 2021 2020
from f000 f000
investments
In t
en		 listedonareco nisedStockExch n e.
In the UK 65 73
Outside the UK 0 0
Unlisted securities:
In the UK 11 16
Outside the UK 6 5
Investments in a Common Deposit Fund
Current account
/ short term interest
Total 83 99

NOTES TO NOTES TO THE FINANCIAL STATE THE FINANCIAL STATE MENTS (CONT INU ED)
Analysis of 13(Continued)
Funds
Combined
Total
Details of 13.3 Restricted Funds Balance Balance
material 1 April Incoming Resources Gains on Gain on 31 March
funds ~ 2020 Resources Expended
Transfers		 Disposals Revaluation 2021
Restricted f000 f000 f000 f000 f000 f000 f000
Funds Material funds
Eye Infirmary
Legacy		 94 (94) 0 0
Leukaemia
Research		 Legacy 71 (2) 23 97
Orthopaedics
bequest		 35 0 0 35
Neonatal
Unit Legacy		 13 0 0 13
Other designated
funds		 23 3 0 22
Total 236 99 8 23 167
13A Description offunds
Eye Infirmary
Legacy		 For the purchase ofmedical equipment
Leukaemia
Research		 Legacy For leukaemia snd lymphoma research.
Orthopsedics
bequest		 For the provision ofan operating theatre bed specifically
designed for people suffering from curvature of the spine
Neonatal
Unit legacy		 For South Tyneside neonates
Combined
Details of 13.5 Unrestricted
Funds		 Total
material Balance Balance
funds- 1 April Incoming Resources Net Gain on Net Gain on 31 March
Unrestricted 2020 Resources Expended
Transfers		 Disposals Revaluation 2021
Funds f000 f000 f000 f000 f000 f000 6000
Material funds
Medical Equipment purposes 672 1,013 (80) 13 1,618
CO)/ID 19 0 548 (20) 6 536
General
Purposes		 538 34 (152) 10 430
Paediatric department 321 11 (3) 6 335
NeoNatal
Unit		 301 16 (8) 6 315
Rise Above Cancer 185 38 (46) 4 181
SRH Coronary
Care		 160 6 (2) 3 167
Glaucoma
purposes		 182 5 (37) 3 153
Maternity
Unit		 162 3 (30) 3 138
Clinical Haematology 152 25 (56) 2 123
Phoenix
Unit
— Chemotherapy		 107 24 (22) 2 111
SEIGeneral
Purposes		 170 29 (97) 2 104
Diabetes purposes Legacy 87 1 (1) 2 89
SRH Ward D46 Strake ( prev ESS,D41) 53 44 (10) 2 89
Orthopaedic
Department		 125 2 (43) 2 86
Elderly Mediine
Wards		 78 1 (6) 2 75
Pharmacy
department		 67 8 (I) 1 75
Renal purposes 43 31 (1) 1 74
MS fund 91 1 (27) 2 67
STDH Cardiology
bequests		 63 I (1) 2 65
Staff Lottery 62 12 (12) 0 62
ENT/SALT purposes 57 4 (1) 1 61
Diagnostic Imaging department 65 1 (7) 1 60
South Tyneside
Community		 Planned Car 50 7 0 1 58
SRH Cardiology 55 2 (1) 1 57
Gynsecology
purposes		 53 1 (1) 1 54
Thoracic Medicine 45 5 (1) 1 50
Other 1236 104 (83) 0 306 1,563
Total Unrestricted Funds 5,180 1 977 0 82 306 8,796
Medical
Equipment
purposes		 Larger items of medical equipment
funded from CHolCE donations.		 Larger items of medical equipment
funded from CHolCE donations.		 Larger items of medical equipment
funded from CHolCE donations.		 Larger items of medical equipment
funded from CHolCE donations.
(incl CHoICE donation)
COVID 19 Trustwide
in accordance
with the objects ofthe		 Charity and conditions
set by NHS Charities Together (incl Captain
Sir Tom Moore distributions).
General
Purposes		 Trustwide
in accordance
with the objects ofthe		 Charity.
Paediatric
department		 Equipment
and patient amenities across Paediatrics
NeoNatal
Unit		 Equipment
and patient amenities
for the Neonates
service
Rise Above Cancer Information,
support and complimentary		 therapy treatment
rooms on
formerly Cancer Support - Macmillan Sunderland
Royal and South Tyneside		 District hospital sites
SRH Coronary
Care		 Equipment,
patient amenities,
training		 within the Unit.
Glaucoma
purposes		 Incorporating
the GRADERS
fund, for glaucoma		 service purposes
including
research
and development
Maternity
Unit		 Equipment
for the maternity
unit and purposes		 in accordance with the
objects ofthe Charity
GRAD@S Glaucoma research
and development		 in Sunderland.
Coronary Care Unit For expenditure
in accordance
with the		 objects ofthe Charity.
Clinical Haematology Equipment,
education
and patient care		 in Clinical Haematology.
(formerly called Blood Disorders)
Phoenix
Unit - Chemotherapy		 Equipment
and patient amenities
within		 the Unit - relocated
SEIGeneral
Purposes		 For Eye Infirmary
benefit
in accordance		 with the objects ofthe Charity.
Diabetes purposes
Legacy		 For expenditure
in accordance
with the		 objects ofthe Charity.
SRH Ward D45 Stroke Equipment
and patient amenities
within		 the ward
(previously
located on ward E58)
Orthopaedic
Department		 Equipment,
training
and education
within the department.
Elderly Mediine Wards For expenditure
in accordance
with the		 objects ofthe Charity.
Pharmacy
department		 Equipment,
training
and education
within the department.
Renal purposes For expenditure
in accordance
with the		 objects ofthe Charity.
MS fund To develop
Multiple Sclerosis services.
STDH Cardiology
bequests		 For expenditure
in accordance
with the		 objects ofthe Charity.
Staff Lottery Staff lottery draw - to benefit STSFThealthcare provision.
(formerly
District Lottery Suspense)
ENT/SALT purposes For purposes
including
Head and Neck cancer		 services
Diagnostic
Imaging
departmen		 Relating
to Radiology and Medical Physics.
South Tyneside
Community		 For expenditure
in accordance
with the		 objects ofthe Charity.
Planned
Care
SRH Cardiology For expenditure
in accordance
with the		 objects ofthe Charity.
Gynaecology
purposes		 For expenditure
in accordance
with the		 objects ofthe Charity.
Thoracic Medicine For expenditure
in accordance
with the		 objects ofthe Charity.

Combined
Charitable
City Hospitals Sunderland South Tyneside Funds
Total Tote I Total
Unrestricted Restricted Endowment 2019/20 Unrestricted Restricted Endowment 2019/20 2019/20
Funds Funds Funds Funds Funds Funds Funds Funds Fuiiila
f000 EOOO EOOO EOOO EOOO EOOO EOOO f000 EOOO
Income from.
Doiistioiia &Legacies 869 0 871 36 0 0 36 907
Charitable Activities 75 0 75 2 0 0 2 77
Other Trading Activities
Investments 54 59 37 40 99
Tots I Income 1,005 0 6 I 1,012 75 3 0 70 1,090
Expenditure
on:
Raising Funds (60) (I) 0 (61) 0 0 0 0 (61)
Charitable Activities (1,156) (1) 0 (1,157) (117) (I) 0 (118) (1,276)
Total Ea
dlture		 (1,216) (2) 0 (1,218) (11 (1) 0 118) (1,336)
Net (Loss)l Gain on Investments (214) (15) 0 (229) 5 0 0 5 (224)
Net (EspeitdHure)l Income )425) 11) I (435) (37) 2 0 35) (470)
Transfer between funds 0 I (I) 0 0 0 0 0
Nel movement
In hinds		 (425) (10) 0 (435) (37) 2 0 (35) (470)
Reconciliation
of Funds:
Total funda brought forward 4,345 179 159 4,682 1,295 67 I 1,363 s,o45
Total funds carried forward 3,920 160 159 4,247 1,250 I 1,320 5,575

Combined
Charitable
City Hospitals Sunderlsnd South Tyneside Funds
Total Total Total
Unrestricted Restricted Endowment 2019/20 Unrestricted Restricted Endowment 2019I20 2019I2D
Funds Funds Funds Funds Funds Funds Funds Funds Funds
f000 EDOO EODO 8000 EOOD EOOD EOOD 8000 EDOD
Non current assets
Investments 1,988 118 0 2,104 0 0 0 0 2,1IN
Total non-current assets 1,986 116 0 2,104 0 0 0 0 2,104
Current assets
Investments 1132 25 I 1158 1,158
Trade and other receivables 20 0 0 20 12 0 0 12 32
Cash and cash e urvalents 2,494 52 159 2,705 27r 46
Total current assets 2,514 52 159 2,725 1,421 71 1 1,493 4,218
Current
liabilities
Trade and other payablea (582) 0 0 (582) (163) (2) 0 (165) R47)
Net current assets 1.932 52 159 2,143 1,258 69
Total net assets 392D 188 159 4247 1 258 69
Retained funds of tha Charity
Endowment
Funds		 D 0 159 159 0 0 I 1 160
Restricted
Income Funds		 0 168 0 169 0 69 0 69 23'I
Unrestricted
Income		 Funds 3.920 0 0 3,920 1,258 0 0 1,258 5,178
Total retained
funds		 3,920 168 159 4,247 1,258 69 1